HLS Therapeutics Inc.
HLS
Rankning i aktier
#21920
HLS Therapeutics Inc. operates as a specialized pharmaceutical firm,... HLS Therapeutics Inc. operates as a specialized pharmaceutical firm, concentrating on the acquisition and commercialization of medicinal products, primarily within the niche central nervous system (CNS) and cardiovascular (CV) sectors. Its reach extends across Canada, the United States, and international markets. The company's core product lineup includes Clozaril, an atypical antipsychotic used in the treatment of schizophrenia; Vascepa, an icosapent ethyl capsule formulation; and PERSERIS, an injectable risperidone product for treating schizophrenia. Additionally, HLS offers MyCare psychiatry laboratory assays and MyCare Insite tests for point-of-care therapeutic drug-level monitoring. Furthermore, the company possesses U.S. marketing privileges for Absorica, a commercial-stage dermatology solution, and Canadian rights for Trinomia, a cardiovascular therapeutic. It also manages a portfolio of royalty interests from four distinct healthcare products. Founded in 2018, HLS Therapeutics Inc. is based in Etobicoke, Canada.
Aktiekurs
$2.94
Marknadsvärde
$91.10M
Förändring (1 dag)
0.24%
Förändring (1 år)
-26.74%
Land
CA
Handel HLS Therapeutics Inc. (HLS)
Kategori
Healthcare
Aktiekurshistorik för HLS Therapeutics Inc. (HLS)
Högsta slutkurs: $2.75 den 2026-10-01
Lägsta slutkurs: $0.42 den 2010-01-01
Lägsta slutkurs: $0.42 den 2010-01-01
Aktiekurshistorik för HLS Therapeutics Inc. från 2010 till 2026
Årlig aktiekursutveckling
| År | Prestanda |
|---|---|
| 2026 (TTM) | -6.37% |
| 2025 | 36.44% |
| 2024 | -11.68% |
| 2023 | -61.22% |
| 2022 | -36.61% |
| 2021 | -14.29% |
| 2020 | -5.41% |
| 2019 | 23.57% |
| 2018 | 504.45% |
| 2017 | 5.61% |
| 2016 | -1.13% |
| 2015 | 1.31% |
| 2014 | -15.58% |
| 2013 | 6.18% |
| 2012 | 24.32% |
| 2011 | 122.54% |
| 2010 | 0.00% |
Aktiekurs för liknande företag eller konkurrenter
| Företag | Aktiekurs | Förändring 1år% | Land |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $165.48 | 23.75% |
DE
|
|
| $40.45 | 43.11% |
JP
|
|
| $224.75 | 31.24% |
CH
|
|
| $18.43 | -4.03% |
IN
|
